Notice to Long-Term Shareholders of LKQ Corporation
Grabar Law Office is investigating potential claims on behalf of long-term shareholders of LKQ Corporation, Molina Healthcare, Inc., Power Solutions International, Inc., and Varonis Systems, Inc. The investigations focus on alleged breaches of fiduciary duties by company officers and misleading statements concerning business operations and financial prospects that led to material misstatements and financial impacts for investors. The law office encourages affected shareholders to contact them to discuss potential corporate reforms, return of funds, or participation in class-action lawsuits.
Notice to Long-Term Shareholders of LKQ Corporation (NASDAQ: LKQ); Molina Healthcare, Inc. (NYSE: MOH); Power Solutions International, Inc. (NASDAQ: PSIX); and Varonis Systems, Inc. (VRNS): Grabar Law Office Investigates Claims on Your Behalf
Grabar Law Office is investigating potential claims on behalf of long-term shareholders of LKQ Corporation (NASDAQ: LKQ), Molina Healthcare, Inc. (NYSE: MOH), Power Solutions International, Inc. (NASDAQ: PSIX), and Varonis Systems, Inc. (VRNS). The investigations concern whether certain officers and/or directors breached their fiduciary duties to the respective companies and their shareholders. Shareholders who held shares prior to specific dates mentioned for each company are encouraged to contact the law office.
Vanguard Group Inc. Sells 353,209 Shares of Molina Healthcare, Inc $MOH
Vanguard Group Inc. reduced its stake in Molina Healthcare, Inc. by 5.5%, selling 353,209 shares but still retaining an 11.22% ownership valued at over $1 billion. Molina Healthcare recently surpassed quarterly EPS estimates with $2.35, though revenue decreased year-over-year. The company's stock currently trades around $192.74, with analysts generally holding a "Hold" rating and an average target price of $169.60.
UnitedHealth Pops 14.5% After Q1 Beat: Still a Buy or Too Late Now?
UnitedHealth Group (UNH) saw its shares climb 14.5% after a strong first-quarter 2026 report, surpassing earnings and revenue expectations due to growth in commercial fee-based membership and Optum Rx strength. Despite improved profitability and a raised EPS guidance for 2026, regulatory and legal risks, along with ongoing membership pressures and current valuation levels, present headwinds. The stock, currently carrying a Zacks Rank #3 (Hold), prompts investors to seek clearer visibility on membership trends and regulatory outcomes before further investment.
Molina Healthcare, Inc $MOH Stock Position Reduced by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH significantly reduced its stake in Molina Healthcare, Inc ($MOH) by 67.5% in the fourth quarter, selling 38,645 shares and retaining 18,625 shares valued at approximately $3.23 million. Despite this reduction, institutional investors collectively own 98.50% of the company's stock, with several other large investors increasing their positions. Analyst sentiment for MOH is mixed, with some upgrades to "Buy" and others maintaining "Hold" or "Sell" ratings, resulting in an average price target of $169.60.
Cwm LLC Has $611,000 Stock Holdings in Molina Healthcare, Inc $MOH
Cwm LLC significantly reduced its stake in Molina Healthcare, Inc (MOH) by 95.4% in Q4, ending with 3,522 shares valued at $611,000. Molina Healthcare reported Q1 EPS of $2.35, beating estimates, but revenue missed at $10.8 billion, a 3.1% year-over-year decrease. Analysts currently hold a consensus "Hold" rating on the stock with a price target of $169.60.
Alignment lifts 2026 outlook as Medicare membership climbs 30.9%
Alignment Healthcare reported strong Q1 2026 financial results, with total revenue increasing by 33.3% year-over-year to $1.24 billion and Medicare Advantage membership growing by 30.9% to approximately 284,800 members. The company also significantly improved its adjusted gross profit and adjusted EBITDA, leading to a raised outlook for membership, revenue, adjusted gross profit, and adjusted EBITDA for both Q2 and the full fiscal year 2026. These results demonstrate disciplined growth and margin expansion, positioning the company for continued scaling.
Vanguard reports 2.7M-share (5.19%) stake in Molina Healthcare (NYSE: MOH)
Vanguard Capital Management has reported a 5.19% stake in Molina Healthcare (NYSE: MOH), as detailed in a recent Schedule 13G SEC filing. This passive investment involves beneficial ownership of 2,704,951 shares as of March 31, 2026, with Vanguard holding sole voting power for 394,721 shares. The filing indicates that various Vanguard affiliated business divisions exercise dispositive and voting power for these holdings.
Vanguard reports 5.25% stake in Masterbrand (MBC) via Schedule 13G
Vanguard Capital Management has reported a 5.25% passive stake in Masterbrand Inc (MBC) through a Schedule 13G filing. This translates to beneficial ownership of 6,705,627 shares, with Vanguard holding sole dispositive power over all these shares and sole voting power over 980,135 shares. The filing, dated April 30, 2026, indicates this is a typical holding for a large asset manager and does not suggest activist intent.
Molina Healthcare Jumps 5.9% After Wells Fargo Maintains Equal-Weight
Molina Healthcare, Inc. (MOH) saw its stock surge 5.9% after five Wall Street firms, including Wells Fargo, raised their price targets by an average of 18.3%. Despite the upgrades, all firms maintained neutral-to-cautious ratings (Underweight, Equal-Weight, Hold), suggesting improved fundamentals but a wait-and-see approach for further catalysts. The average new price target across these firms is $165, which is still below Wednesday's closing price.
Vanguard Portfolio Management (MOH) reports 2.8M shares, 5.37% stake
Vanguard Portfolio Management has reported a beneficial ownership of 2,801,121 shares in Molina Healthcare Inc. (MOH), representing a 5.37% stake as of March 31, 2026. This Schedule 13G filing indicates a passive investment, with Vanguard having sole dispositive power over all these shares but sole voting power over only 10,150 shares. The filing underscores that this stake is held across various Vanguard funds and managed accounts, with no intention of influencing corporate control.
Molina Healthcare Jumps 5.9% After Wells Fargo Maintains Equal-Weight
Molina Healthcare's stock surged 5.9% to $196.43 after five Wall Street firms raised their price targets by an average of 18.3%. While analysts expressed renewed confidence in the company, most maintained neutral-to-cautious ratings, suggesting they are awaiting further catalysts before more bullish recommendations. Investors should monitor future enrollment data and margin guidance for potential rating upgrades.
Provident Financial Holdings Misses Q3 2026 EPS by 34.4%, Results
Provident Financial Holdings (NASDAQ:PROV) reported Q3 2026 diluted EPS of $0.21, significantly missing the $0.32 estimate by 34.4%. The regional bank's net income was $1.4M, with a year-over-year EPS decline of 25.0%. The market reaction was muted, and analyst sentiment remains cautious with no buy ratings.
Fiverr International Releases Q1 2026 Financial Results
Fiverr International Ltd. (FVRR) reported mixed Q1 2026 financial results, narrowly beating Wall Street expectations despite a decline in revenue. The company posted diluted non-GAAP net income of $0.62 per share and revenue of $105.5 million, but saw a 1.6% decrease in top-line revenue year-over-year. Management issued cautious guidance for Q2, projecting continued pressure on the business.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Molina Healthcare, Inc. (MOH) and Encourages Stockholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Molina Healthcare, Inc. (MOH). The firm is encouraging stockholders who purchased Molina securities before February 5, 2025, and still hold them, to come forward and assist in the investigation. The firm operates on a contingency fee basis and seeks to recover investor capital and ensure corporate accountability.
Transamerica Mid Cap Value Opportunities's Molina Healthcare Inc(MOH) Holding History
This article details Transamerica Mid Cap Value Opportunities's investment history in Molina Healthcare Inc (MOH). As of January 31, 2026, the fund held 47,000 shares valued at $8.44 million, representing 1.04% of its portfolio. The initial trade was in Q1 2026, and the fund has since gained an estimated $1.55 million, a 20.07% return on its investment in MOH.
Molina Healthcare Jumps 5.7% After Wells Fargo Maintains Equal-Weight
Molina Healthcare (MOH) surged 5.7% to $189.44 after five major Wall Street firms, including Truist Securities, UBS, Wells Fargo, Morgan Stanley, and Barclays, raised their price targets on the managed care provider. Despite the increased price targets, the analysts largely maintained neutral or negative ratings, highlighting a cautious optimism about the company's prospects. The average new price target across these firms is $165, which is below Molina's current trading price.
Molina Healthcare Inc. stock outperforms competitors on strong trading day
Molina Healthcare Inc. (MOH) shares rose 3.48% to $185.46, outperforming the broader market which saw the S&P 500 and Dow Jones Industrial Average decline. This marks the ninth consecutive day of gains for Molina Healthcare. The strong performance occurred on a generally rough trading day for the stock market.
Ciena Drops 7.5% Amid Sector-Wide Selling
Ciena Corporation (CIEN) saw its shares tumble 7.5% to $468.42 on Tuesday due to a broad sector-wide selloff impacting communication equipment stocks. The decline was not linked to company-specific news but rather a synchronized downdraft among its peers, indicating a widespread investor rotation out of the sector. This coordinated selling suggests macro forces or sector-specific concerns are at play, prompting Ciena shareholders to assess whether it's a temporary shakeout or a broader repricing.
DuPont de Nemours (NYSE:DD) Price Target Raised to $52.00 at Morgan Stanley
Morgan Stanley has increased its price target for DuPont de Nemours (NYSE:DD) to $52.00 from $44.00, reiterating an "equal weight" rating, suggesting an 11.59% potential upside. The company reported quarterly EPS of $0.46, surpassing estimates, and set FY2026 guidance between $2.25 and $2.30 EPS. The stock currently trades around $46.60, with institutional investors holding a significant 73.96% of the shares.
Molina Healthcare (MOH) price target increased by 11.11% to 166.42
This article reports that Molina Healthcare (MOH) has received an increased price target of $166.42, representing an 11.11% rise. The content provided is minimal, indicating this is likely an announcement of an analyst's revised target for the company's stock.
Notice to Long-Term Shareholders of Coty Inc. (NYSE: COTY);
Grabar Law Office is investigating claims against Coty Inc. (NYSE: COTY), LKQ Corporation (NASDAQ: LKQ), Molina Healthcare, Inc. (NYSE: MOH), and Power Solutions International, Inc. (NASDAQ: PSIX) on behalf of long-term shareholders. The investigations concern alleged breaches of fiduciary duties by company officers and directors and aim to seek corporate reforms and the return of funds to the companies. Shareholders who held shares before specified dates can learn more about participating in these shareholder governance actions.
Curbline Properties Releases Q1 2026 Financial Results
Curbline Properties Corp. (NYSE: CURB) announced strong Q1 2026 financial results, exceeding analyst expectations with an Operating FFO of $0.28 per share and revenue of $58.0 million, marking a 49.9% year-over-year increase. The company's aggressive portfolio expansion and solid same-property net operating income growth contributed to its success. Management provided optimistic guidance for FY 2026, forecasting Operating FFO between $1.20 and $1.23, and Wall Street holds a largely bullish outlook on the stock.
Investors Panicked on CoreWeave. Why It Might Be Time to Get Greedy
CoreWeave (CRWV) recently recovered significantly after a 60% drop, boosted by new AI deals and analyst upgrades targeting $125-$150 per share. The neocloud infrastructure firm's competitive advantages, including priority access to Nvidia GPUs and its "Mission Control" operating system for AI, are now being recognized by the market amidst surging demand for hyperscale compute. Despite existing debt, CoreWeave's solid backlog and analysts' increased bullishness suggest strong future growth potential.
Broadwood Partners, Neal C. Bradsher buy $2.03m of Insight Molecular Diagnostics
Broadwood Partners, along with its general partner Broadwood Capital Inc. and its president Neal C. Bradsher, recently increased their stake in Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) by acquiring shares worth over $2 million. These purchases occurred between April 23 and April 27, 2026, with share prices ranging from $3.5025 to $3.6391, despite the stock being down significantly year-to-date. The company is advancing towards commercialization, with recent milestones including the submission of its GraftAssureDx assay to the FDA and expansion into heart transplant testing, leading Needham to reiterate a Buy rating.
Morgan Stanley Adjusts First Solar PT to $230 From $275, Maintains Overweight Rating
Morgan Stanley has adjusted its price target for First Solar (FSLR) to $230 from $275, while maintaining an Overweight rating on the stock. This adjustment comes amidst other recent analyst revisions for First Solar, indicating a general re-evaluation of the company's valuation. The article also provides recent news and company profile details for First Solar.
JPMorgan Adjusts Price Target on Elevance Health to $411 From $397, Maintains Overweight Rating
JPMorgan has raised its price target for Elevance Health (ELV) to $411 from $397, while reiterating an Overweight rating on the stock. This adjustment reflects an updated outlook from the financial institution regarding the healthcare company's valuation. The report was published on April 28, 2026.
Molina Healthcare Inc. stock underperforms Monday when compared to competitors despite daily gains
Molina Healthcare Inc. (MOH) stock rose 1.86% to $179.22 on Monday, marking its eighth consecutive day of gains. Despite this daily increase, the stock underperformed compared to its competitors, with the S&P 500 Index also increasing. The Dow Jones Industrial Average experienced a slight decline on the same day.
Molina Healthcare (MOH) Is Up 19.4% After Reaffirming EPS Guidance Despite Sharp Q1 Profit Drop – Has The Bull Case Changed?
Molina Healthcare (MOH) reported a significant net income drop in Q1 2026 but reaffirmed its full-year adjusted EPS guidance, leading to a 19.4% stock price increase. The company's investment narrative heavily relies on its ability to control medical costs and manage product mix shifts amid Medicaid attrition and revenue pressures. Despite the positive market reaction to reaffirming guidance, increased Medicaid attrition and rising medical cost trends remain potential challenges for investors.
The MolinaCares Accord Provides $100,000 Grant to Lurie Children’s in Support of Statewide School Mental Health Initiative
The MolinaCares Accord has granted $100,000 to Lurie Children’s Hospital of Chicago's Center for Childhood Resilience to support the Resilience-Supportive Schools Illinois (RSSI) initiative. This funding will help expand RSSI's efforts in equipping schools with data-driven tools and resources to improve student and educator mental health and well-being across Illinois. The initiative provides free support to schools, enabling them to create trauma-responsive and healing-centered learning environments.
Molina Healthcare (MOH) Valuation Check After Earnings Beat And Reaffirmed 2026 EPS Guidance
Molina Healthcare (MOH) recently reported strong Q1 2026 earnings, beating expectations and reaffirming its full-year adjusted EPS guidance despite lower revenue forecasts. While a discounted cash flow model suggests the stock is 57% undervalued with a fair value of $411.65, its current P/E ratio of 48.7x is significantly higher than industry averages, signaling potential valuation risk. Investors are encouraged to further analyze the company's prospects and financial health.
Bronstein, Gewirtz & Grossman, LLC Encourages Molina Healthcare, Inc. (MOH) Investors to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Molina Healthcare, Inc. (MOH) on behalf of investors who purchased securities prior to February 5, 2025, and still hold them. The investigation focuses on whether Molina and its officers engaged in corporate wrongdoing. The firm encourages affected investors to contact them to assist with the securities investigation, which is conducted on a contingency fee basis.
M&T Bank Corp Buys 34,751 Shares of Molina Healthcare, Inc $MOH
M&T Bank Corp increased its stake in Molina Healthcare, Inc (NYSE:MOH) by 451.1% in the fourth quarter, purchasing an additional 34,751 shares and bringing its total holdings to 42,455 shares valued at $7.37 million. This move comes as other institutional investors also adjusted their positions in Molina Healthcare, which recently reported strong Q1 EPS results but faces challenges with declining revenue and membership due to its exit from the unprofitable MA-Part D business. Analyst opinions are mixed, with some upgrading sentiment due to improved cost control and others remaining cautious about future growth and Medicaid spending uncertainty.
Molina Healthcare, Inc $MOH Shares Sold by Asset Management One Co. Ltd.
Asset Management One Co. Ltd. significantly reduced its stake in Molina Healthcare (NYSE:MOH) by 91.6% in the fourth quarter. This comes as Molina Healthcare reported strong Q1 EPS, beating analyst expectations, but experienced a decline in revenue and membership due to exiting unprofitable Medicare Advantage Prescription Drug (MAPD) business. Despite mixed analyst reactions and a "Hold" consensus rating, institutional ownership in the company remains high at 98.5%, with other large firms increasing their positions.
Elevance Health Inc (ELV) Stock Price, Trades & News
GuruFocus provides a detailed overview of Elevance Health Inc (ELV), a leading US health insurer. The article includes real-time stock data, financial strength indicators, growth ranks, profitability metrics, and a summary of recent news and analyst estimates. Notably, it highlights ELV's strong market position due to its Blue Cross Blue Shield affiliation and its expanding presence in government-sponsored programs and healthcare services.
Notice to Long-Term Shareholders of BellRing Brands,
The Grabar Law Office is investigating claims on behalf of long-term shareholders of BellRing Brands, Inc. (NYSE: BRBR), Coty Inc. (NYSE: COTY), LKQ Corporation (NASDAQ: LKQ), and Molina Healthcare, Inc. (NYSE: MOH). The investigations concern alleged breaches of fiduciary duties by officers and directors and materially false or misleading statements that impacted the companies' business, operations, and prospects. Shareholders who purchased shares before specific dates are encouraged to contact the law office to seek corporate reforms and the return of funds.
UBS Adjusts Price Target on Molina Healthcare to $180 From $151, Maintains Neutral Rating
UBS has increased its price target for Molina Healthcare (MOH) to $180 from $151, while choosing to maintain a "Neutral" rating on the stock. This adjustment reflects an updated valuation for the managed healthcare provider. The article also notes that Deutsche Bank similarly adjusted its price target for Molina Healthcare earlier the same day.
Deutsche Bank Adjusts Molina Healthcare PT to $129 From $109, Maintains Hold Rating
Deutsche Bank has increased its price target for Molina Healthcare (NYSE:MOH) to $129 from $109 while maintaining a Hold rating on the stock. This adjustment comes amidst Molina Healthcare's recent financial performance, including beating Q1 adjusted earnings and controlled medical costs. The article suggests this news is reserved for members, prompting registration to unlock the full content.
Molina Healthcare, Inc. (NYSE:MOH) Q1 2026 Earnings Call Transcript
Molina Healthcare reported solid first-quarter 2026 results with adjusted EPS of $2.35 on $10.2 billion in premium revenue, reaffirming its full-year guidance of approximately $42 billion in premium revenue and at least $5 in adjusted EPS. The company noted a 91.1% consolidated MCR, driven by strong operating performance despite a challenging medical cost environment, and expressed confidence that the acuity shift trend seen in 2025 is behind them. They anticipate updating the full-year guidance after Q2 results, citing prudence given current market dynamics.
Aetna says 95% of eligible care approvals clear within 24 hours
Aetna announced significant progress in simplifying its prior authorization process, with 88% of volume standardized and over 95% of eligible requests approved within 24 hours. The company also reported processing 83% of prior authorizations in real-time and eliminating over 1 million provider calls through automation. Aetna is integrating medical and pharmacy decisions into single reviews and launching bundled programs to streamline approvals further.
Patterson-UTI Energy Hits Day High with Strong 8.09% Intraday Surge
Patterson-UTI Energy, Inc. saw a significant intraday surge of 8.09%, reaching a high of USD 10.58, and has outperformed the S&P 500 over the past year despite challenges like low profitability and consecutive quarterly losses. The company's stock has generated a 35.56% return over the last year, outperforming the market, though a decrease in promoter stake raises some concerns. Its current market capitalization stands at USD 4,699 million within the small-cap segment.
Twin Vee PowerCats increases base salary for vice president to $250,000
Twin Vee PowerCats Co. has increased the base salary of its Vice President, Preston Yarborough, to $250,000 annually, a decision approved by the Compensation Committee. This change is reflected in an amendment to Mr. Yarborough's employment agreement. The company recently completed a $2.5 million stock offering, named a new exclusive dealer, and reincorporated in Nevada, while also facing a delisting notice from Nasdaq due to not meeting the minimum bid price requirement.
Jabil declares $0.08 quarterly dividend payable June 2
Jabil Inc. announced a quarterly dividend of $0.08 per share, payable on June 2, 2026, to shareholders of record as of May 15, 2026. This continues their 21-year streak of consecutive quarterly cash dividends. Despite the stock appearing overvalued by InvestingPro analysis, Jabil reported strong Q2 fiscal 2026 results, with increased revenue, robust AI and server demand, and raised price targets from several analysts.
Lockheed Martin vs. RTX: Defense Spending Is Surging — Here’s Who Wins
Lockheed Martin (LMT) and RTX (RTX) both reported strong Q4 results, benefiting from surging global defense budgets and the expanding U.S. missile defense agenda. Lockheed Martin, a pure-play defense company, boasts a record $194 billion all-defense backlog and significant F-35 deliveries. In contrast, RTX offers a diversified aerospace portfolio with a $268 billion backlog split between commercial and defense, providing structural resilience through its commercial aftermarket business.
3 iShares India ETFs to Buy Before 2026 as Growth Powers Past the US
India's economy is projected to continue outperforming developed nations in growth, making US-listed ETFs an attractive option for investors seeking exposure to Indian equities. This article discusses three prominent iShares India ETFs—INDA, INDY, and EPI—each offering a distinct investment approach ranging from broad market-cap-weighted exposure to concentrated mega-cap holdings or earnings-weighted portfolios. While all three have experienced recent pullbacks due to valuation concerns, foreign outflows, and currency weakness, their long-term performance demonstrates how different methodologies tailor risk and return profiles for investors.
MOH Q1 EPS Tops Estimates on Lower Medical Costs, Membership Declines
Molina Healthcare (MOH) reported first-quarter 2026 adjusted earnings per share of $2.35, surpassing the Zacks Consensus Estimate, despite a 61.3% decline from the prior year. Revenues of $10.8 billion marginally missed expectations, decreasing 3.1% year over year, primarily due to reduced premiums, membership, and investment income. The company maintained its full-year 2026 premium revenue guidance of $42 billion and reaffirmed adjusted earnings guidance of at least $5.00 per diluted share.
Molina Healthcare Inc. stock outperforms competitors on strong trading day
Molina Healthcare Inc.'s stock (MOH) surged by 14.18% to $174.70 on Thursday, contrasting with a general downturn in the market as the S&P 500 and Dow Jones Industrial Average both declined. This marked the sixth consecutive day of gains for the company's shares.
Raymond James Just Lifted Etsy's Target to $75. Has This Beaten-Down E-Commerce Name Finally Bottomed?
Raymond James raised its price target for Etsy (ETSY) to $75 from $60, maintaining an Outperform rating, signaling confidence in the e-commerce company's potential stabilization. This upgrade comes ahead of Etsy's Q1 2026 earnings report on April 29, which will be a key test for the recovery thesis, given the stock's 40% gain over the past year but 70% decline over five years. The bank's analyst believes Etsy's Q1 GMS will show signs of stabilizing demand and an inflection point after a multi-year decline, making the stock's 22x forward P/E valuation seem reasonable for patient investors eyeing a potential turnaround.
Molina Healthcare MOH Jumps As EPS Tops Views, CMS Lifts 2027 Rates
Molina Healthcare (MOH) saw its stock jump by 12.57% after reporting Q1 2026 adjusted EPS of $2.35, exceeding expectations despite a slight revenue miss and membership decline. The company reaffirmed its 2026 adjusted EPS guidance of at least $5.00 and approximately $42 billion in premium revenue. Additionally, shares climbed following the CMS finalization of 2027 Medicare Advantage and Part D rates, which included an average 2.48% revenue increase.
Molina Healthcare soars 15% after beating Q1 earnings, reaffirms FY26 guidance
Molina Healthcare reported strong first-quarter earnings that surpassed analyst expectations, driven by higher-than-anticipated Medicaid revenue. The company also reaffirmed its full-year 2026 earnings guidance, leading to a significant 15% surge in its stock price. This positive performance was attributed to effective management of medical costs and growth in its core business segments.
